Neurology, Neurocritical Care
-
-
Administers Grant
-
A Multicenter, Double-Blind, Placedbo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG0002) on reducing Infarct volume in Acute Ischemic Stroke.
-
A Phase 1B/2. Multiccenter,Doubleblind Placebo-controlled, Randomized, Single-Ascending dose study to assess the safety, Pharmacokinetics and pharmacodynamics of DS-1040B in Subjects with Acute Ischemic Stroke.
-
A Phase 2,PlaceboControlled,Randomized,Double-Blind,Parallel-Arm Study to EvaluateEfficacy and Safety of BMS-986141For the Prevention of Recurrent Brain Infarction in Subjects receiving acetylsalicyclic acid(ASA)followingAcute Ischemic Stroke or TIA
-
A Randomized, Double-Blind, MultiNational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA (SOCRATES)
-
ApoE-mimetic peptides protect against brain injury
-
Apolipoprotein E effect on the CNS immune response
-
Apolipoprotein E effecton the CNS immune response.
-
Assessment of Application Tools for Electroencephalography Leads and EEG Recording Equipment in the ICU.
-
Development of Brain Monitoring technology: Neurologic Injury Monitoring with Real-time Output Display (NIMROD)
-
Effects of rGDF11 on Functional Recovery Following Traumatic Brain Injury (TBI) in Mice
-
Extract of Erigeron breviscapus protects against brain injury in stroke
-
Eythropotien Peptides & Traumatic Brain Injury
-
Genetic variation, stress, and functional outcomes after stroke rehabilitation
-
IPA- Hana Dawson
-
Karyopharm Theapeutics Clinipace Project
-
Linearized apoE peptide mimetic is neuroprotective in acute cerebrovascular disease
-
Medically ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism RISK (MARINER)
-
Neuroprotective pentapeptide improves outcome after ischemic stroke and subarachnoid hemorrhage
-
Novel anti-neuroinflammatory drug for aneurysmal subarachnoid hemorrhage (aSAH)
-
Phase 1/2 A Multicenter, Controlled, Randomized, Open-Label, Dose Escalation, Safety. Tolerability and Pharmocokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage.
-
Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal subarachnoid Hemorrhage
-
Prophylactic administration of CN-105 confers neuroprotection against acute brain injury
-
Proteo improves outcomes after closed head injury and subarachnoid hemorrhage
-
Randomized Double Blind Placebo-Controlled Parallel Group, MultiCenter Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Larg
-
Secondary Stroke Prevention Study comparing Dabigatran vs Acetylsalicylic Acid in patients with Embolic Stroke of Undetermined Source RE-SPECT ESUS
-
The Effect Of Apoe On Cholinergic Neuron Survival
-
Trangenic Mouse Model of Alzheimer's Disease
-
pH dependent neuroprotective agents improve outcome in murine SAH
-
rGDF11 improves outcomes after closed head injury and intracranial hemorrhage
-
same